Annovis Bio(ANVS) - 2024 Q2 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 15, 2024 ANNOVIS BIO, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-39202 (State or Other Jurisdiction of Incorporation) (Commission File Number) | --- | --- | --- | |-------|----------------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | 26-2540421 | | ...